Protective effects of Vitamin D3 on fimbrial cells exposed to catalytic iron damage

Francesca Uberti, Vera Morsanuto, Debora Lattuada, Barbara Colciaghi, Andrea Cochis, Alessandro Bulfoni, Paola Colombo, Giorgio Bolis, Claudio Molinari

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Recently, vitamin D3 (1alpha, 25-dihydroxyvitamin D) has shown its capability to take part in many extraskeletal functions and its serum levels have been related to patient survival rate and malignancy of many types of neoplasms, including ovarian cancers. Catalytic iron is a free circulating form of iron that is able to generate reactive oxygen species and consequently to promote a number of cellular and tissutal dysfunctions including tumorigenesis. In fertile women an important source of catalytic iron is derived from retrograde menstruation. Epithelial secretory cells from fimbriae of fallopian tubes are greatly exposed to catalytic iron derived from menstrual reflux and so represent the site of origin for most serous ovarian cancers. The aim of this study was to assess whether vitamin D3 can play a role in counteracting catalytic iron-induced oxidative stress in cells from fimbriae of fallopian tubes. Methods: The cells, isolated from women undergoing isteroannessiectomy, were treated with catalytic iron 50-75-100 mM and vitamin D3 at a concentration ranging from 0.01 to 10 nM to study cell viability, radical oxygen species production, p53, pan-Ras, Ki67 and c-Myc protein expressions through Western Blot, and immunocytochemistry or immunofluorescence analysis. Results: The pre-treatment with vitamin D3 1 nM showed its beneficial effects that consists in a significant decrease in ROS production. In addition a novel finding is represented by the demonstration that pre-treatment with vitamin D3 is also able to significantly counteract tumoral biomarkers activation, such as p53, pan-Ras, Ki67 and c-Myc, and consequently the catalytic iron-induced cellular injury. Conclusions: This study demonstrates for the first time that vitamin D3 plays an important role in preventing catalytic iron-dependent oxidative stress in cultured fimbrial cells. These results support the hypothesis that vitamin D3 could counteract carcinogenic changes induced by catalytic iron.

Original languageEnglish
Article number34
JournalJournal of Ovarian Research
Volume9
Issue number1
DOIs
Publication statusPublished - Jun 17 2016

Fingerprint

Cholecalciferol
Iron
Fallopian Tubes
Ovarian Neoplasms
Reactive Oxygen Species
Oxidative Stress
Menstruation Disturbances
Proto-Oncogene Proteins c-myc
Dihydroxycholecalciferols
Fluorescent Antibody Technique
Cultured Cells
Neoplasms
Cell Survival
Carcinogenesis
Survival Rate
Biomarkers
Western Blotting
Epithelial Cells
Immunohistochemistry
Wounds and Injuries

Keywords

  • Catalytic iron
  • Epithelial ovarian cancer
  • Fimbrial secretory epithelial cells
  • Vitamin D

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynaecology

Cite this

Protective effects of Vitamin D3 on fimbrial cells exposed to catalytic iron damage. / Uberti, Francesca; Morsanuto, Vera; Lattuada, Debora; Colciaghi, Barbara; Cochis, Andrea; Bulfoni, Alessandro; Colombo, Paola; Bolis, Giorgio; Molinari, Claudio.

In: Journal of Ovarian Research, Vol. 9, No. 1, 34, 17.06.2016.

Research output: Contribution to journalArticle

Uberti, F, Morsanuto, V, Lattuada, D, Colciaghi, B, Cochis, A, Bulfoni, A, Colombo, P, Bolis, G & Molinari, C 2016, 'Protective effects of Vitamin D3 on fimbrial cells exposed to catalytic iron damage', Journal of Ovarian Research, vol. 9, no. 1, 34. https://doi.org/10.1186/s13048-016-0243-x
Uberti, Francesca ; Morsanuto, Vera ; Lattuada, Debora ; Colciaghi, Barbara ; Cochis, Andrea ; Bulfoni, Alessandro ; Colombo, Paola ; Bolis, Giorgio ; Molinari, Claudio. / Protective effects of Vitamin D3 on fimbrial cells exposed to catalytic iron damage. In: Journal of Ovarian Research. 2016 ; Vol. 9, No. 1.
@article{73182ef00fbc4c3ba67ad0b20588c50d,
title = "Protective effects of Vitamin D3 on fimbrial cells exposed to catalytic iron damage",
abstract = "Background: Recently, vitamin D3 (1alpha, 25-dihydroxyvitamin D) has shown its capability to take part in many extraskeletal functions and its serum levels have been related to patient survival rate and malignancy of many types of neoplasms, including ovarian cancers. Catalytic iron is a free circulating form of iron that is able to generate reactive oxygen species and consequently to promote a number of cellular and tissutal dysfunctions including tumorigenesis. In fertile women an important source of catalytic iron is derived from retrograde menstruation. Epithelial secretory cells from fimbriae of fallopian tubes are greatly exposed to catalytic iron derived from menstrual reflux and so represent the site of origin for most serous ovarian cancers. The aim of this study was to assess whether vitamin D3 can play a role in counteracting catalytic iron-induced oxidative stress in cells from fimbriae of fallopian tubes. Methods: The cells, isolated from women undergoing isteroannessiectomy, were treated with catalytic iron 50-75-100 mM and vitamin D3 at a concentration ranging from 0.01 to 10 nM to study cell viability, radical oxygen species production, p53, pan-Ras, Ki67 and c-Myc protein expressions through Western Blot, and immunocytochemistry or immunofluorescence analysis. Results: The pre-treatment with vitamin D3 1 nM showed its beneficial effects that consists in a significant decrease in ROS production. In addition a novel finding is represented by the demonstration that pre-treatment with vitamin D3 is also able to significantly counteract tumoral biomarkers activation, such as p53, pan-Ras, Ki67 and c-Myc, and consequently the catalytic iron-induced cellular injury. Conclusions: This study demonstrates for the first time that vitamin D3 plays an important role in preventing catalytic iron-dependent oxidative stress in cultured fimbrial cells. These results support the hypothesis that vitamin D3 could counteract carcinogenic changes induced by catalytic iron.",
keywords = "Catalytic iron, Epithelial ovarian cancer, Fimbrial secretory epithelial cells, Vitamin D",
author = "Francesca Uberti and Vera Morsanuto and Debora Lattuada and Barbara Colciaghi and Andrea Cochis and Alessandro Bulfoni and Paola Colombo and Giorgio Bolis and Claudio Molinari",
year = "2016",
month = "6",
day = "17",
doi = "10.1186/s13048-016-0243-x",
language = "English",
volume = "9",
journal = "Journal of Ovarian Research",
issn = "1757-2215",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Protective effects of Vitamin D3 on fimbrial cells exposed to catalytic iron damage

AU - Uberti, Francesca

AU - Morsanuto, Vera

AU - Lattuada, Debora

AU - Colciaghi, Barbara

AU - Cochis, Andrea

AU - Bulfoni, Alessandro

AU - Colombo, Paola

AU - Bolis, Giorgio

AU - Molinari, Claudio

PY - 2016/6/17

Y1 - 2016/6/17

N2 - Background: Recently, vitamin D3 (1alpha, 25-dihydroxyvitamin D) has shown its capability to take part in many extraskeletal functions and its serum levels have been related to patient survival rate and malignancy of many types of neoplasms, including ovarian cancers. Catalytic iron is a free circulating form of iron that is able to generate reactive oxygen species and consequently to promote a number of cellular and tissutal dysfunctions including tumorigenesis. In fertile women an important source of catalytic iron is derived from retrograde menstruation. Epithelial secretory cells from fimbriae of fallopian tubes are greatly exposed to catalytic iron derived from menstrual reflux and so represent the site of origin for most serous ovarian cancers. The aim of this study was to assess whether vitamin D3 can play a role in counteracting catalytic iron-induced oxidative stress in cells from fimbriae of fallopian tubes. Methods: The cells, isolated from women undergoing isteroannessiectomy, were treated with catalytic iron 50-75-100 mM and vitamin D3 at a concentration ranging from 0.01 to 10 nM to study cell viability, radical oxygen species production, p53, pan-Ras, Ki67 and c-Myc protein expressions through Western Blot, and immunocytochemistry or immunofluorescence analysis. Results: The pre-treatment with vitamin D3 1 nM showed its beneficial effects that consists in a significant decrease in ROS production. In addition a novel finding is represented by the demonstration that pre-treatment with vitamin D3 is also able to significantly counteract tumoral biomarkers activation, such as p53, pan-Ras, Ki67 and c-Myc, and consequently the catalytic iron-induced cellular injury. Conclusions: This study demonstrates for the first time that vitamin D3 plays an important role in preventing catalytic iron-dependent oxidative stress in cultured fimbrial cells. These results support the hypothesis that vitamin D3 could counteract carcinogenic changes induced by catalytic iron.

AB - Background: Recently, vitamin D3 (1alpha, 25-dihydroxyvitamin D) has shown its capability to take part in many extraskeletal functions and its serum levels have been related to patient survival rate and malignancy of many types of neoplasms, including ovarian cancers. Catalytic iron is a free circulating form of iron that is able to generate reactive oxygen species and consequently to promote a number of cellular and tissutal dysfunctions including tumorigenesis. In fertile women an important source of catalytic iron is derived from retrograde menstruation. Epithelial secretory cells from fimbriae of fallopian tubes are greatly exposed to catalytic iron derived from menstrual reflux and so represent the site of origin for most serous ovarian cancers. The aim of this study was to assess whether vitamin D3 can play a role in counteracting catalytic iron-induced oxidative stress in cells from fimbriae of fallopian tubes. Methods: The cells, isolated from women undergoing isteroannessiectomy, were treated with catalytic iron 50-75-100 mM and vitamin D3 at a concentration ranging from 0.01 to 10 nM to study cell viability, radical oxygen species production, p53, pan-Ras, Ki67 and c-Myc protein expressions through Western Blot, and immunocytochemistry or immunofluorescence analysis. Results: The pre-treatment with vitamin D3 1 nM showed its beneficial effects that consists in a significant decrease in ROS production. In addition a novel finding is represented by the demonstration that pre-treatment with vitamin D3 is also able to significantly counteract tumoral biomarkers activation, such as p53, pan-Ras, Ki67 and c-Myc, and consequently the catalytic iron-induced cellular injury. Conclusions: This study demonstrates for the first time that vitamin D3 plays an important role in preventing catalytic iron-dependent oxidative stress in cultured fimbrial cells. These results support the hypothesis that vitamin D3 could counteract carcinogenic changes induced by catalytic iron.

KW - Catalytic iron

KW - Epithelial ovarian cancer

KW - Fimbrial secretory epithelial cells

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=84975873845&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975873845&partnerID=8YFLogxK

U2 - 10.1186/s13048-016-0243-x

DO - 10.1186/s13048-016-0243-x

M3 - Article

VL - 9

JO - Journal of Ovarian Research

JF - Journal of Ovarian Research

SN - 1757-2215

IS - 1

M1 - 34

ER -